Spironolactone is contraindicated with which of the following drugs:
**Core Concept**
Spironolactone is a potassium-sparing diuretic that acts as an antagonist to the mineralocorticoid receptor, leading to increased sodium excretion and water retention. This results in increased potassium levels. Therefore, it is essential to avoid combining spironolactone with other medications that may also increase potassium levels, potentially leading to hyperkalemia.
**Why the Correct Answer is Right**
The combination of spironolactone with other potassium-sparing agents or drugs that inhibit potassium excretion can lead to significant hyperkalemia. This is particularly concerning in patients with pre-existing renal impairment or those taking other medications that may affect potassium levels. The mechanism of spironolactone is to block the action of aldosterone, leading to increased potassium levels. Combining it with other potassium-sparing agents or potassium-retaining drugs can further exacerbate this effect.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because spironolactone is not contraindicated with beta-blockers. Beta-blockers are used to treat hypertension, angina, and heart failure, and they do not have a significant effect on potassium levels.
**Option B:** This option is incorrect because spironolactone is not contraindicated with nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs can affect renal function and increase blood pressure, but they do not have a significant effect on potassium levels.
**Option C:** This option is incorrect because spironolactone is contraindicated with potassium-sparing diuretics like amiloride (Midamor) and triamterene (Dyrenium). These medications also increase potassium levels and can lead to hyperkalemia when combined with spironolactone.
**Clinical Pearl / High-Yield Fact**
When prescribing spironolactone, it is essential to monitor potassium levels regularly, especially in patients with renal impairment or those taking other medications that may affect potassium levels. Additionally, patients should be advised to report any signs or symptoms of hyperkalemia, such as muscle weakness or fatigue.
**Correct Answer: C. Amiloride (Midamor) and triamterene (Dyrenium)**